Suchergebnisse - "Mertens, Daniel"

PubPharm (166)

11

Modeling the B-cell receptor signaling on single cell level reveals a stable network circuit topology between nonmalignant B cells and chronic lymphocytic leukemia cells and between untreated cells and cells treated with kinase inhibitors

enthalten in: International journal of cancer | 2022

von Wolf, C. | Maus, C. | Persicke, M. | +8

12

Hydroxylation of the NOTCH1 intracellular domain regulates Notch signaling dynamics

enthalten in: Cell death & disease | 2022

von Ferrante, F. | Giaimo, B. | Friedrich, T. | +10

13

Clonal evolution in chronic lymphocytic leukemia is scant in relapsed but accelerated in refractory cases after chemo(immune) therapy

enthalten in: Haematologica | 2022

von Zapatka, M. | Tausch, E. | Öztürk, S. | +9

14

Integrative prognostic models predict long-term survival after immunochemotherapy in chronic lymphocytic leukemia patients

enthalten in: Haematologica | 2022

von Bloehdorn, J. | Krzykalla, J. | Holzmann, K. | +13

15

Evaluation of vecabrutinib as a model for noncovalent BTK/ITK inhibition for treatment of chronic lymphocytic leukemia

enthalten in: Blood | 2022

von Jebaraj, B. | Müller, A. | Dheenadayalan, R. | +15

CommentIn: Blood. 2022 Feb 10;139(6):804-805. - PMID 35142854

16

Atypical enteropathogenic E. coli are associated with disease activity in ulcerative colitis

enthalten in: Gut microbes | 2022

von Baumgartner, M. | Zirnbauer, R. | Schlager, S. | +15

17

Multi-platform profiling characterizes molecular subgroups and resistance networks in chronic lymphocytic leukemia

enthalten in: Nature communications | 2021

von Bloehdorn, J. | Braun, A. | Taylor-Weiner, A. | +31

18

Discovery of Candidate DNA Methylation Cancer Driver Genes

enthalten in: Cancer discovery | 2021

von Pan, H. | Renaud, L. | Chaligne, R. | +16

19

Methylome-based cell-of-origin modeling (Methyl-COOM) identifies aberrant expression of immune regulatory molecules in CLL

enthalten in: bioRxiv.org | 2021

von Wierzbinska, J. | Toth, R. | Ishaque, N. | +17

20

Triggering T-cell activity in CLL

enthalten in: Blood | 2021

von Mertens, D. | Krönke, J.

CommentOn: Blood. 2021 Jan 14;137(2):216-231. - PMID 33024998